辰欣药业：股东石四药累计减持公司股份452万股，减持计划完成

Group 1 - The company, Chenxin Pharmaceutical, announced on September 24, 2025, that it received a notification from Shisi Pharmaceutical regarding the completion of a share reduction plan, where Shisi Pharmaceutical reduced its holdings by 4,520,000 shares, accounting for 0.998% of the total share capital [1][1][1] - For the year 2024, Chenxin Pharmaceutical's revenue composition indicates that the pharmaceutical manufacturing sector contributed 99.75% to the total revenue, while other businesses accounted for only 0.25% [1][1][1] - As of the report date, Chenxin Pharmaceutical has a market capitalization of 9.3 billion yuan [1][1][1] Group 2 - The A-share market reached a total market value of over 116 trillion yuan on the anniversary of the "9.24" event, indicating significant changes in the Chinese capital market [1][1][1]